Neurobiology of Aging
Volume 28, Issue 3 , Pages 371-376 , March 2007

Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons

  • Roberta Ghidoni

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • These authors contributed equally to this work.
    • ,
  • Luisa Benussi

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • These authors contributed equally to this work.
    • ,
  • Anna Paterlini

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • ,
  • Cristina Missale

      Affiliations

    • Division of Pharmacology, Department of Biomedical Sciences and Biotechnology, Centre of Excellence on Diagnostic and Therapeutic Innovation, University of Brescia, Brescia, Italy
    • ,
  • Alessia Usardi

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • ,
  • Rossana Rossi

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • ,
  • Laura Barbiero

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • ,
  • PierFranco Spano

      Affiliations

    • Division of Pharmacology, Department of Biomedical Sciences and Biotechnology, Centre of Excellence on Diagnostic and Therapeutic Innovation, University of Brescia, Brescia, Italy
    • ,
  • Giuliano Binetti

      Affiliations

    • NeuroBioGen Lab-Memory Clinic, IRCCS “Centro S. Giovanni di Dio-FBF”, AFaR, Brescia, Italy
    • Corresponding Author InformationCorresponding author at: NeuroBioGen Lab-Memory Clinic, IRCCS “Centro San Giovanni di Dio-Fatebenefratelli”, via Pilastroni 4, 25125 Brescia, Italy. Tel.: +39 030 3501709; fax: +39 030 3533513.

Received 30 May 2005 ,Revised 30 December 2005 ,Accepted 21 January 2006.

References 

  1. Babiloni C, Benussi L, Binetti G, Bosco P, Busonero G, Cesaretti S, et al. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study. Neuroimage. 2006;29:948–964
  2. Benussi L, Alberici A, Mayhaus M, Langer U, Ghidoni R, Mazzoli F, et al. Detection of the presenilin 1 COOH-terminal fragment in the extracellular compartment: a release enhanced by apoptosis. Exp Cell Res. 2001;269(2):256–265
  3. Benussi L, Ghidoni R, Steinhoff T, Alberici A, Villa A, Mazzoli F, et al. Alzheimer disease-associated cystatin C variant undergoes impaired secretion. Neurobiol Dis. 2003;13(1):15–21
  4. Benussi L, Ghidoni R, Paterlini A, Nicosia F, Alberici AC, Signorini S, et al. Interaction between tau and alpha-synuclein proteins is impaired in the presence of P301L tau mutation. Exp Cell Res. 2005;308(1):78–84
  5. Binetti G, Signorini S, Squitti R, Alberici A, Benussi L, Cassetta E, et al. Atypical dementia associated to a novel presenilin-2 mutation. Ann Neurol. 2003;54(6):832–836
  6. Crawford FC, Freeman MJ, Schinka JA, Abdullah LI, Gold M, Hartman R, et al. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology. 2000;55(6):763–768
  7. Cruts M, van Duijin CM, Backhovens H, Van den Broeck M, Wehnert A, Serneels S, et al. Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet. 1998;7(1):43–51
  8. Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol. 2001;159(3):1061–1068
  9. Finckh U, Alberici A, Antoniazzi M, Benussi L, Fedi V, Giannini C, et al. Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I. Neurology. 2000;54(10):2006–2008
  10. Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, et al. Genetic Association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol. 2000;57(11):1579–1583
  11. Giacomello M, Barbiero L, Zatti G, Squitti R, Binetti G, Pozzan T, et al. Reduction of Ca2+ stores and capacitative Ca2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiol Dis. 2005;18(3):638–648
  12. Higuchi M, Lee VM, Trojanowski JQ. Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med. 2002;2(2):131–150
  13. Kempermann G, Kuhn HG, Gage FH. More hippocampal neurons in adult mice living in an enriched environment. Nature. 1997;386(6624):493–495
  14. Lee VM, Daughenbaugh R, Trojanowski JQ. Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol Aging. 1994;15:S87–S89
  15. Levy E, Sastre M, Kumar A, Gallo G, Piccardo P, Ghetti B, et al. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients. J Neuropathol Exp Neurol. 2001;60(1):94–104
  16. Lofberg H, Grubb AO. Quantitation of gamma-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest. 1979;39(7):619–626
  17. Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. Cell culture. Progenitor cells from human brain after death. Nature. 2001;411(6833):42–43
  18. Paraoan L, Ratnayaka A, Spiller DG, Hiscott P, White MR, Grierson I. Unexpected intracellular localization of the AMD-associated cystatin C variant. Traffic. 2004;5(11):884–895
  19. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci. 2003;23(11):4499–4508
  20. Roy S, Zhang B, Lee VM, Trojanowski JQ. Axonal transport defects: a common theme in neurodegenerative diseases. Acta Neuropathol (Berl). 2005;109(1):5–13
  21. Sastre M, Calero M, Pawlik M, Mathews PM, Kumar A, Danilov V, et al. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging. 2004;25(8):1033–1043
  22. Takeda K, Araki W, Tabira T. Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci. 2004;19(2):258–264
  23. Taupin P, Ray J, Fischer WH, Suhr ST, Hakansson K, Grubb A, et al. FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor. Neuron. 2000;28(2):385–397
  24. Tennant JR. Evaluations of the trypan blue technique for determination of cell viability. Transplantation. 1964;12:685–694
  25. Zatti G, Ghidoni R, Barbiero L, Binetti G, Pozzan T, Fasolato C, et al. The presenilin 2 M239I mutation associated with familial Alzheimer's disease reduces Ca2+ release from intracellular stores. Neurobiol Dis. 2004;15(2):269–278

PII: S0197-4580(06)00039-X

doi: 10.1016/j.neurobiolaging.2006.01.007

Neurobiology of Aging
Volume 28, Issue 3 , Pages 371-376 , March 2007

Article Tools

* Image Usage & Resolution